• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Guggenheim S&P 500 Equal Weight Healthcare ETF

+ Add to Watchlist

RYH:US

144.8500 USD 0.6400 0.44%

As of 16:15:05 ET on 12/22/2014.

Snapshot for Guggenheim S&P 500 Equal Weight Healthcare ETF (RYH)

Open: 145.4000 High - Low: 145.4000 - 144.1300 Primary Exchange: NYSE Arca
Volume: 38,391 52-Week Range: 109.0600 - 146.0999 Beta vs SPXEWHC: 0.9816

ETF Chart for RYH

No chart data available.
  • RYH:US 144.8500
  • 1D
  • 1M
  • 1Y
145.4900
Interactive RYH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RYH

Guggenheim S&P Equal Weight Healthcare ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate the performance of the S&P Equal Weight Health Care Index.

Inception Date: 2006-11-07 Telephone: 1-888-949-3837
Managers: MICHAEL PAUL BYRUM / JAMES R KING
Web Site: guggenheiminvestments.com

Fundamentals for RYH

NAV (on 2014-12-19) 145.2088
Assets (M) (on 2014-12-19) 479.1888
Shares out (M) 3.30
Market Cap (M) 478.01
% Premium 0.19
Average 52-Week % Premium 0.0192
Fund Leveraged N

Dividends for RYH

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-12-19) 0.1458
Dividend Yield (ttm) 0.42%

Performance for RYH

1-Month +4.18% 1-Year +35.05%
3-Month +11.14% 3-Year +32.60%
Year To Date +32.39% 5-Year +21.79%
Expense Ratio 0.40

Top Fund Holdings for RYH

Filing Date: 12/19/2014
Name Position Value % of Total
Edwards Lifesciences Corp 77,777 10,360,674 2.166%
Celgene Corp 84,709 9,926,201 2.075%
Vertex Pharmaceuticals Inc 83,373 9,913,050 2.072%
CareFusion Corp 167,115 9,884,852 2.066%
Allergan Inc/United States 45,807 9,739,942 2.036%
Regeneron Pharmaceuticals Inc 22,404 9,580,847 2.003%
Amgen Inc 56,224 9,567,638 2.000%
Becton Dickinson and Co 68,175 9,531,547 1.992%
Mylan Inc/PA 164,738 9,474,082 1.980%
Bristol-Myers Squibb Co 154,250 9,455,525 1.976%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil